Clinical Trials on Eye Infections, Bacterial

Total 80110 results

Johns Hopkins Bloomberg School of Public Health

Completed

Etiology, Prevention and Treatment of Neonatal Infections in the Community

Infectious Disease | Bacterial Infection

Bangladesh
The Methodist Hospital Research Institute
M.D. Anderson Cancer Center; National Institute of Allergy and Infectious Diseases... and other collaborators

Recruiting

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)

Antibiotic Resistant Infection | Clostridium Difficile | Antimicrobial Drug Resistance | Carbapenem-Resistant Enterobacteriaceae Infection | Vancomycin Resistant Enterococci Infection | Vancomycin-Resistant Enterococcal Infection | Carbapenem Resistant Bacterial Infection | Extended Spectrum Beta-Lactamase...

United States
Kirby Institute

Not yet recruiting

PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised. (PATH)

Invasive Fungal Infections | Infection, Bacterial | Infection, Fungal | Injection Site Infection | Infection, Soft Tissue | Invasive Bacterial Infection
National Eye Institute (NEI)

Completed

Clinical Trial of Eye Prophylaxis in the Newborn

Chlamydia Infections | Ophthalmia Neonatorum
National Eye Institute (NEI)

Completed

Helicobacter Pylori and Dry Eye

Helicobacter Infections

United States
L.V. Prasad Eye Institute

Unknown

Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis (NATA_VORI)

Infection, Fungal

India
Centre d'Appui à la lutte contre la Maladie
International Trachoma Initiative

Completed

Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination (AZIVAL)

Parasitic Diseases | Bacterial Diseases

Mali
Singapore General Hospital
National Medical Research Council (NMRC), Singapore

Recruiting

Evaluating a Novel Individualised Treatment Strategy for Carbapenem-Resistant Gram-Negative Bacteria Infections

Antibiotic Therapy

Singapore
Clinical Hospital Centre Zagreb

Not yet recruiting

Therapeutic Options for CRAB (TheraCRAB)

Infections, Bacterial | Sepsis Bacterial
GlaxoSmithKline

Completed

Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections

Infections, Bacterial

United States
Emory University

Withdrawn

Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis (AZIVAL2)

Lymphatic Filariasis | Trachoma

Mozambique
University of California, San Francisco
Aravind Eye Hospitals, India

Unknown

Cross-linking for Corneal Ulcers Treatment Trial (CLAIR)

Corneal Ulcer | Infectious Keratitis | Bacterial Ulcer | Fungal Ulcer

United States, India
Lihir Medical Centre
London School of Hygiene and Tropical Medicine

Completed

Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )

Yaws | Scabies | Lymphatic Filariases | Trachoma | Strongyloidiasis

Papua New Guinea
Ministry of Health, Rwanda

Unknown

A Trial Assessing Efficacy of Various Antimicrobial Techniques for Reducing Bacterial Load (RMC-11)

Disease Due to Gram-positive Bacteria

Rwanda
Melinta Therapeutics, LLC

Recruiting

Study to Evaluate the Safety and Tolerability of Single-Dose Intravenous (IV) Oritavancin

Acute Bacterial Skin and Skin Structure Infection

United States, Spain, Greece, Portugal, Bulgaria, Latvia, Romania, Lithuania, Poland
Aziende Chimiche Riunite Angelini Francesco S.p.A
Hippocrates Research

Completed

Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With ABSSSI (REDS)

Acute Bacterial Skin and Skin Structure Infection

Greece, Italy
The University of Queensland
Merck Sharp & Dohme LLC

Withdrawn

Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection (MERINO III)

Bacteremia Caused by Gram-Negative Bacteria

Spain, Australia, Singapore, Italy, Saudi Arabia
Hospices Civils de Lyon

Completed

Staphylococcus Lugdunensis Prosthetic Joint Infection

Staphylococcal Infections | Prosthetic Joint Infection

France
University of Alabama at Birmingham

Terminated

Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates

Respiratory Tract Infections | Bacteria Infection

United States
Allergan

Completed

Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers

Bacterial Keratitis | Acute Bacterial Corneal Ulcers

United States, India
Mayo Clinic
Ortho-McNeil, Inc.

Completed

The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection

Staphylococcal Infection | Staphylococcus Aureus Prosthetic Joint Infection

United States
Novartis
Novartis Vaccines

Completed

Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings

Bacterial Infection | Streptococcal Infection | Gram-positive Bacterial Infection

Belgium, Canada
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections

Skin Diseases, Bacterial

Hong Kong, Korea, Republic of, United States, Philippines, Singapore, Canada, Thailand, Israel, Taiwan, Lebanon, Malaysia, South Africa
Arpida AG

Completed

Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)

Skin Diseases, Bacterial

United States
London School of Hygiene and Tropical Medicine
Federal Minstry of Health of Ethiopia; Armauer Hansen Research Institute, Ethiopia

Completed

Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin

Lymphatic Filariases | Trachoma

Ethiopia
Ludwig-Maximilians - University of Munich
Santen Gmbh

Completed

Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular Surgery

Conjunctival Bacterial Flora

Germany
University Hospital, Brest
Centre de Référence des Infections Ostéo-Articulaires du Grand Ouest

Completed

Retrospective Study of Bone Infection Due to Campylobacter Spp (CAMPYLO)

Bone Diseases, Infectious | Campylobacter Infections

France
University of Duhok

Not yet recruiting

Parenteral Versus Combined Parenteral With Vancomycin-soaked Graft in ACL Reconstruction

Infection, Bacterial
Melinta Therapeutics, Inc.
Department of Health and Human Services

Completed

Pharmacokinetics and Safety of Solithromycin in Adolescents and Children

Bacterial Infection

United States, Bulgaria
Assistance Publique Hopitaux De Marseille

Unknown

Therapeutic Drug Monitoring of Anti-infectious Drugs in Intensive Care Unit (STP-ATB-REA)

Infection, Bacterial
Johnson & Johnson Pharmaceutical Research & Development...
PriCara, Unit of Ortho-McNeil, Inc.

Completed

A Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin Infections

Skin Diseases, Bacterial
GlaxoSmithKline

Completed

GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection

Skin Infections, Bacterial

United States
Pfizer
Allergan

Terminated

Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants. (NOOR)

Gram-negative Bacterial Infection

United States, Hungary, Slovakia, Taiwan, India, Estonia, Greece, Italy
Pfizer

Completed

Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections

Gram-negative Bacterial Infection

Australia
Jena University Hospital

Terminated

PERFORM = Pentaglobin® Registry For Outcome Report and Monitoring (PERFORM)

Severe Bacterial Infection

Brazil, Colombia, Germany, Turkey
Trius Therapeutics LLC

Completed

Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections

Skin Diseases, Infectious | Skin Diseases, Bacterial

United States
Federal University of São Paulo

Terminated

Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery

Inflammation | Bacterial Infections

Brazil
Fakultas Kedokteran Universitas Indonesia

Enrolling by invitation

The Effectivity of Anti Tuberculosis Therapy in Idiopathic Uveitis With Positive IGRA

Tuberculous Uveitis

Indonesia
Arrevus Inc.

Completed

Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections

Skin Diseases, Bacterial

United States
GlaxoSmithKline

Completed

Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects

Infections, Bacterial

United States
GlaxoSmithKline

Terminated

A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects

Infections, Bacterial

United States
GlaxoSmithKline

Completed

Amoxicillin Bioequivalence Study Brazil - Fast

Infections, Bacterial

Brazil
GlaxoSmithKline

Withdrawn

A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women

Infections, Bacterial
The Medicines Company

Completed

A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Acute Bacterial Skin and Skin Structure Infection

United States
GlaxoSmithKline

Completed

Drug-drug Interaction Study of Gepotidacin

Infections, Bacterial

United States
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Completed

Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function

Infections, Bacterial

United States
GlaxoSmithKline

Terminated

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830

Infections, Bacterial

Australia
GlaxoSmithKline

Completed

Relative Bioavailability Study in Healthy Subjects (PDF112034)

Infections, Bacterial

United States
GlaxoSmithKline

Completed

A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects

Infections, Bacterial

Australia
University of Maryland, Baltimore

Terminated

Targeted Gown and Glove Intervention in Nursing Homes (TAGG)

Staphylococcus Aureus | Carbapenem Resistant Gram Negative Bacteria

United States

Clinical Trials on Eye Infections, Bacterial

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations